Therapeutic Nanobodies Targeting Cell Plasma Membrane ...

& Melero, J. A. Generation and characterization of ALX-0171, a potent novel therapeutic nanobody for the treatment of respiratory syncytial virus infection.







A bivalent spike-targeting nanobody with anti-sarbecovirus activity
Ozoralizumab, a bi-nanobody-based BsAb featuring two anti-TNF? nanobodies and one anti-HAS nanobody, is currently undergoing phase 2 clinical.
VHH Trimer Paper_mAbs_submission_v3.docx - bioRxiv
This bispecific nanobody prevents SARS-CoV-2 from infecting host cells through ACE2, and blocks the excessive inflammatory response triggered by ...
Nanobody-Based EGFR-Targeting Immunotoxins for Colorectal ...
Verheul, H. M. W., de Gruijl, T. D., & van der Vliet, H. J. (2014). Bispecific antibody · platforms for cancer immunotherapy. Critical Reviews ...



Autres Cours:

Nanobody - MDPI